

| マトレヤ社の脂質・糖脂質のご紹介 |
全製品の掲載ではありません。すべての製品の検索は こちらからできます。 |
| Synthetic Sphingosines ( 99 % pure by TLC and GC ) |
| Supplied neat. Storage : 4 ℃ |
| Product Name |
D-erythro |
L-threo |
L-erythro |
D-threo |
Sphingosine
FW 299.5 |
1802
25 mg |
1806
10 mg |
1826
5 mg |
$ 1827
5 mg |
| Cat.# |
Description |
Pkg. |
| 1304 |
Sphingosine ( semi-synth. from bovine CNS ) D(+)-erythro-2-amino-
4(E)-octadecene-1, 3-diol,
FW 299.5 |
10 mg |
Dihydro-Sphingosine Isomers
Supplied neat. Storage : 4 ℃ |
| Product Name |
D-erythro |
L-threo |
L-erythro |
D-threo |
Dihydro-Sphingosine
FW 301.5 |
1831
25 mg |
1807
1 mg |
1846
1 mg |
1851
1 mg |

| Cerebrosides ( 99 % by TLC ) |
| Cat.# |
Description |
Pkg. |
| 1050 |
Cerebrosides ( Ceramide galactosides, bovine, gal-cer )
FW 812 ( lignocery ) wt. % N 1.69 |
50 mg |
| 1057 |
Glucocerebrosides ( Gaucher's spleen, Glc-cer )
FW 812 ( lignocery ) |
5 mg |
 |

| Product Name> |
D-erythro |
L-threo |
L-erythro |
D-threo |
C2-Ceramide
FW 341.5 acetyl |
1901
10 mg |
1829
1 mg |
1847
1 mg |
|
C6-Ceramide
FW 397.5 hexanoyl |
1900
10 mg |
1828
1mg |
1848
1 mg |
1809
1 mg |
C8-Ceramide
FW 425.5 octanoyl |
1903
10 mg |
1830
1mg |
カスタム品 |
1810
1 mg |
C18-Ceramide
FW 565.7 stearoyl |
1832
10 mg |
#1843
1 mg |
#1850
1 mg |
#1855
1 mg |

| Cat.# |
Description |
Pkg. |
| 1834 |
D-erythro-C2-dihydro-Ceramide
( N-acetyl ) FW 343.5 |
1 mg |
| 1910 |
D-erythro-C6-dihydro-Ceramide>
( N-hexanoyl ) FW 399.5 |
10 mg |
| 1854 |
D-erythro-C8-dihydro-Ceramide
( N-octanoyl ) FW 427.5 |
1 mg |

| Fluorescent Ceramides ( 99 % by TLC ) allow the study of ceramide |
| translocation and distribution inside cells. |
| Supplied neat. Storage : - 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1841 |
D-erythro-C6-NBD-Ceramide
( N-NBD-amino-hexanoyl ) FW 574.7 |
100 ug |
| 1857 |
L-threo-C6-NBD-Ceramide
( N-NBD-amino-hexanoyl ) FW 574.7 |
100 ug |
| Cat.# |
Description |
Pkg. |
| 1056 |
Ceramides
natural N-acyl-sphingosin, wt % N2.20,
FW 565 ( stearoyl ) |
25 mg |
| 1322 |
Ceramides
like 1056 but with mostly non-hydroxy fatty acid side chain |
10 mg |
| 1323 |
Ceramides |
10 mg |
| Lactosyl Ceramides (99% by TLC) |
| Supplied neat, storage: - 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1500 |
Lactosyl Ceramides |
1 mg |
| 1517 |
lyso-Lactosyl Ceramide |
1 mg |
| 1507 |
Lactosyl ceramides (bovine buttermilk) |
5 mg |

| Bovine Brain Gangliosides |
| Supplied neat, storage: - 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1065 |
Purified Mixed Gangliosides |
25 mg |
| 1512 |
Gangliotriosyl ceramide (Asialo-GM2) |
100 ug |
| Other Gangliosides ( 99 % by TLC ) |
| Cat.# |
Description |
Pkg. |
| 1503 |
Monosialoganglioside GM3
Containing acetylneuraminic acid - NANA, from bovine buttermilk. |
0.5 mg |
| 1504 |
Disialogangliosides GD3
Buttermilk. Gen |
1 mg |

| Monoclonal Antibodies(Supernatant) |
| Storage:- 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1977 |
Mouse Anti-Ganglioside GD3, Isotype IgG |
50 ul |
| Polyclonal Antibodies(Serum) |
| Storage:- 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1950 |
Rabbit Anti-Asialo-GM1, Isotype IgG |
100 ul |
| 1951 |
Rabbit Anti-Asialo-GM2, Isotype IgG, IgM |
50 ul |
| 1954 |
Rabbit Anti-Ganglioside-GM1, Isotype IgG |
100 ul |
| 1957 |
Rabbit Anti-Ganglioside-GM4, Isotype IgG |
50 ul |
| 1960 |
Rabbit Anti-Globoside-GL4, Isotype IgM |
50 ul |

| Inositols |
| Supplied neat, Storage: - 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1773 |
Phosphatidylinositol 3-phosphate, diPaimitoyl (PI-3,P) |
100 μg |
| 1774 |
Phosphatidylinositol bis-3,4-phosphate, diPaimitoyl (PI-3,4-P2) |
100 μg |
| 1775 |
Phosphatidylinositol tris-3,4,5-phosphate, diPaimitoyl (PI-3,4,5-P3) |
100 μg |

| Pure CLA Isomers |
| Supplied neat, Storage:- 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1245 |
9(Z), 11(E)-Octadecadienoic Acid |
25 mg |
| 1181 |
9(E), 11(E)-Octadecadienoic Acid |
25 mg |
| 1248 |
9(Z), 11(Z)-Octadecadienoic Acid |
25 mg |
| 1249 |
10(E), 12(Z)-Octadecadienoic Acid |
25 mg |
| Enzyme Inhibitors (99% Pure by TLC) |
| Supplied neat, Storage:- 20 ℃ |
| Cat.# |
Description |
Pkg. |
| 1719 |
d,l-threo-PDMP (1-phenyl-2-decanoylamino-3morpholino-1-propanol・HCL) |
100 mg |
| 1756 |
d-threo-PDMP |
10 mg |
| 1749 |
L-threo-PDMP |
10 mg |
| 1720 |
d,l-threo-PPMP (1-phenyl-2-hexadecanoylamino-3-morpholino-1-propanol・HCL) |
100 mg |
| 1865 |
d-threo-PPMP |
10 mg |
| 1868 |
l-threo-PPMP |
10 mg |
| 1721 |
カスタム品:d,l-threo-lyso-PDMP (1-phenyl-2-amino-3-morpholino-1-propanol・2HCL) |
|
| 1755 |
d,l-erythro PDMP |
100 mg |
| 1753 |
d,l-erythro PPMP |
100 mg |

| 製品情報は掲載時点のものですので、ご覧いただくタイミングにより製品情報が変更されている場合があります。 |
|